GANYMED PHARMACEUTICALS AG

Organization

MAINZ, DE

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Antibodies specific for claudin 6 (CLDN6)
- Patent number 11,858,988
- Issue date Jan 2, 2024
- GANYMED PHARMACEUTICALS GMBH
- Ugur Sahin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Antibodies for treatment of cancer expressing claudin 6
- Patent number 11,859,008
- Issue date Jan 2, 2024
- GANYMED PHARMACEUTICALS GMBH
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions for diagnosis and treatment of cancer
- Patent number 11,473,085
- Issue date Oct 18, 2022
- GANYMED PHARMACEUTICALS GMBH
- Ugur Sahin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Claudin-6-specific immunoreceptors and t cell epitopes
- Patent number 11,345,731
- Issue date May 31, 2022
- BioNtech Cell & Gene Therapies GmbH
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies for treatment of cancer expressing claudin 6
- Patent number 10,919,974
- Issue date Feb 16, 2021
- GANYMED PHARMACEUTICALS GMBH
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cancer therapy using CLDN6 target-directed antibodies in vivo
- Patent number 10,844,133
- Issue date Nov 24, 2020
- GANYMED PHARMACEUTICALS GMBH
- Ugur Sahin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies specific for claudin 6 (CLDN6)
- Patent number 10,745,477
- Issue date Aug 18, 2020
- GANYMED PHARMACEUTICALS GMBH
- Ugur Sahin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Agents for treatment of claudin expressing cancer diseases
- Patent number 10,717,780
- Issue date Jul 21, 2020
- BioNTech AG
- Ugur Sahin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Genetic products differentially expressed in tumors and the use the...
- Patent number 10,414,824
- Issue date Sep 17, 2019
- Ganymed Pharmaceuticals AG
- Ugur Sahin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Claudin-6-specific immunoreceptors and T cell epitopes
- Patent number 10,370,423
- Issue date Aug 6, 2019
- Biotech Cell & Gene thrapies GMBH
- Ugur Sahin
- G01 - MEASURING TESTING
Information Patent Grant
Antibodies for treatment of cancer expressing claudin 6
- Patent number 10,233,253
- Issue date Mar 19, 2019
- Ganymed Pharmaceuticals AG
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Monoclonal antibodies against claudin-18 for treatment of cancer
- Patent number 10,174,104
- Issue date Jan 8, 2019
- GANYMED PHARMACEUTICALS GMBH
- Ugur Sahin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Therapy involving antibodies against Claudin 18.2 for treatment of...
- Patent number 10,137,195
- Issue date Nov 27, 2018
- GANYMED PHARMACEUTICALS GMBH
- Ugur Sahin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Monoclonal antibodies for treatment of cancer
- Patent number 10,125,196
- Issue date Nov 13, 2018
- Ganymed Pharmaceuticals AG
- Ugur Sahin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Agents for treatment of claudin expressing cancer diseases
- Patent number 10,093,736
- Issue date Oct 9, 2018
- BioNTech AG
- Ugur Sahin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies against claudin 18.2 useful in cancer diagnosis
- Patent number 10,053,512
- Issue date Aug 21, 2018
- Ganymed Pharmaceuticals AG
- Ugur Sahin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Identification of surface-associated antigens for tumor diagnosis a...
- Patent number 10,036,753
- Issue date Jul 31, 2018
- Ganymed Pharmaceuticals AG
- Ugur Sahin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Combination therapy involving antibodies against Claudin 18.2 for t...
- Patent number 10,022,444
- Issue date Jul 17, 2018
- Ganymed Pharmaceuticals AG
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Monoclonal antibodies against claudin-18 for treatment of cancer
- Patent number 10,017,564
- Issue date Jul 10, 2018
- GANYMED PHARMACEUTICALS GMBH
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies specific for claudin 6 (CLDN6)
- Patent number 9,932,401
- Issue date Apr 3, 2018
- Ganymed Pharmaceuticals AG
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Identification of tumor-associated antigens for diagnosis and therapy
- Patent number 9,919,036
- Issue date Mar 20, 2018
- Ganymed Pharmaceuticals AG
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cancer therapy using CLDN6 target-directed antibodies in vivo
- Patent number 9,902,778
- Issue date Feb 27, 2018
- Ganymed Pharmaceuticals AG
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions for diagnosis and treatment of cancer
- Patent number 9,809,815
- Issue date Nov 7, 2017
- Ganymed Pharmaceuticals AG
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody to genetic products differentially expressed in tumors and...
- Patent number 9,775,785
- Issue date Oct 3, 2017
- Ganymed Pharmaceuticals AG
- Ozlem Tureci
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination therapy involving antibodies against claudin 18.2 for t...
- Patent number 9,770,487
- Issue date Sep 26, 2017
- Ganymed Pharmaceuticals AG
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Monoclonal antibodies against claudin-18 for treatment of cancer
- Patent number 9,751,934
- Issue date Sep 5, 2017
- Ganymed Pharmaceuticals AG
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Identification of tumour-associated cell surface antigens for diagn...
- Patent number 9,733,251
- Issue date Aug 15, 2017
- Ganymed Pharmaceuticals, AG
- Özlem Türeci
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cancer therapy using CLDN6 target-directed antibodies in vivo
- Patent number 9,718,886
- Issue date Aug 1, 2017
- Ganymed Pharmaceuticals AG
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions for diagnosis and treatment of cancer
- Patent number 9,637,548
- Issue date May 2, 2017
- Ganymed Pharmaceuticals AG
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies against Claudin 18.2 useful in cancer diagnosis
- Patent number 9,512,232
- Issue date Dec 6, 2016
- Ganymed Pharmaceuticals AG
- Ugur Sahin
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
ANTIBODIES FOR TREATMENT OF CANCER EXPRESSING CLAUDIN 6
- Publication number 20240101703
- Publication date Mar 28, 2024
- Ganymed Pharmaceuticals GmbH
- Ugur Sahin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES SPECIFIC FOR CLAUDIN 6 (CLDN6)
- Publication number 20240092896
- Publication date Mar 21, 2024
- Ganymed Pharmaceuticals GmbH
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CANCER THERAPY USING CLDN6 TARGET-DIRECTED ANTIBODIES IN VIVO
- Publication number 20240084033
- Publication date Mar 14, 2024
- Ganymed Pharmaceuticals GmbH
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DRUG CONJUGATES COMPRISING ANTIBODIES AGAINST CLAUDIN 18.2
- Publication number 20230270878
- Publication date Aug 31, 2023
- Ganymed Pharmaceuticals GmbH
- Ugur Sahin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF CANCER
- Publication number 20230193261
- Publication date Jun 22, 2023
- Ganymed Pharmaceuticals GmbH
- Ugur Sahin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CLAUDIN-6-SPECIFIC IMMUNORECEPTORS AND T CELL EPITOPES
- Publication number 20220306711
- Publication date Sep 29, 2022
- BIONTECH CELL & GENE THERAPIES GMBH
- Ugur SAHIN
- G01 - MEASURING TESTING
Information Patent Application
ANTIBODIES FOR TREATMENT OF CANCER EXPRESSING CLAUDIN 6
- Publication number 20210179730
- Publication date Jun 17, 2021
- Ganymed Pharmaceuticals GmbH
- Ugur Sahin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CANCER THERAPY USING CLDN6 TARGET-DIRECTED ANTIBODIES IN VIVO
- Publication number 20210079113
- Publication date Mar 18, 2021
- Ganymed Pharmaceuticals GmbH
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Agents for Treatment of Claudin Expressing Cancer Diseases
- Publication number 20200399370
- Publication date Dec 24, 2020
- BIONTECH AG
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DIAGNOSIS AND THERAPY OF CANCER INVOLVING CANCER STEM CELLS
- Publication number 20200385460
- Publication date Dec 10, 2020
- BIONTECH AG
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES SPECIFIC FOR CLAUDIN 6 (CLDN6)
- Publication number 20200339677
- Publication date Oct 29, 2020
- Ganymed Pharmaceuticals GmbH
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CLAUDIN-6-SPECIFIC IMMUNORECEPTORS AND T CELL EPITOPES
- Publication number 20190389920
- Publication date Dec 26, 2019
- BIONTECH CELL & GENE THERAPIES GMBH
- Ugur SAHIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF CANCER
- Publication number 20190169614
- Publication date Jun 6, 2019
- GANYMED PHARMACEUTICALS AG
- Ugur Sahin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR TREATMENT OF...
- Publication number 20190076525
- Publication date Mar 14, 2019
- Ganymed Pharmaceuticals GmbH
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Agents for Treatment of Claudin Expressing Cancer Diseases
- Publication number 20190055311
- Publication date Feb 21, 2019
- BIONTECH AG
- Ugur Sahin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES FOR TREATMENT OF CANCER EXPRESSING CLAUDIN 6
- Publication number 20190010244
- Publication date Jan 10, 2019
- GANYMED PHARMACEUTICALS AG
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR T...
- Publication number 20180326059
- Publication date Nov 15, 2018
- GANYMED PHARMACEUTICALS AG
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES AGAINST CLAUDIN 18.2 USEFUL IN CANCER DIAGNOSIS
- Publication number 20180319891
- Publication date Nov 8, 2018
- GANYMED PHARMACEUTICALS AG
- Ugur Sahin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATION THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR T...
- Publication number 20180258180
- Publication date Sep 13, 2018
- GANYMED PHARMACEUTICALS AG
- Ugur Sahin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES SPECIFIC FOR CLAUDIN 6 (CLDN6)
- Publication number 20180162938
- Publication date Jun 14, 2018
- GANYMED PHARMACEUTICALS AG
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CANCER THERAPY USING CLDN6 TARGET-DIRECTED ANTIBODIES IN VIVO
- Publication number 20180142033
- Publication date May 24, 2018
- GANYMED PHARMACEUTICALS AG
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MONOCLONAL ANTIBODIES AGAINST CLAUDIN-18 FOR TREATMENT OF CANCER
- Publication number 20180127489
- Publication date May 10, 2018
- GANYMED PHARMACEUTICALS AG
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DRUG CONJUGATES COMPRISING ANTIBODIES AGAINST CLAUDIN 18.2
- Publication number 20180117174
- Publication date May 3, 2018
- Ganymed Pharmaceuticals GmbH
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF CANCER
- Publication number 20180119146
- Publication date May 3, 2018
- GANYMED PHARMACEUTICALS AG
- Ugur Sahin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS AND COMPOSITIONS FOR PREDICTION OF THERAPEUTIC EFFICACY OF...
- Publication number 20180073077
- Publication date Mar 15, 2018
- Ganymed Pharmaceuticals GmbH
- Ugur Sahin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMBINATION THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR T...
- Publication number 20180000900
- Publication date Jan 4, 2018
- GANYMED PHARMACEUTICALS AG
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Genetic Products Differentially Expressed In Tumors And The Use The...
- Publication number 20170320963
- Publication date Nov 9, 2017
- GANYMED PHARMACEUTICALS AG
- Ugur Sahin
- G01 - MEASURING TESTING
Information Patent Application
GENETIC PRODUCTS DIFFERENTIALLY EXPRESSED IN TUMORS AND THE USE THE...
- Publication number 20170240646
- Publication date Aug 24, 2017
- GANYMED PHARMACEUTICALS AG
- Ozlem Tureci
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GENETIC PRODUCTS DIFFERENTIALLY EXPRESSED IN TUMORS AND USE THEREOF
- Publication number 20170101479
- Publication date Apr 13, 2017
- GANYMED PHARMACEUTICALS AG
- Ugur Sahin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Monoclonal Antibodies for Treatment of Cancer
- Publication number 20170058044
- Publication date Mar 2, 2017
- GANYMED PHARMACEUTICALS AG
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Trademarklast 30 trademarks

Information Trademark
85850550 - CLAUDETECT
- Serial number 85850550
- Registration number 4820410
- Filing date Feb 14, 2013
- Ganymed Pharmaceuticals AG
- 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
Information Trademark
85850578 - GANYMED
- Serial number 85850578
- Registration number 4820411
- Filing date Feb 14, 2013
- Ganymed Pharmaceuticals AG
- 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
Information Trademark
76686277 - GANYMED
- Serial number 76686277
- Registration number 3759635
- Filing date Jan 29, 2008
- Ganymed Pharmaceuticals AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
76488861 - MEMBRANOME
- Serial number 76488861
- Registration number 2932361
- Filing date Feb 6, 2003
- Ganymed Pharmaceuticals AG
- 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
Information Trademark
76488863 - MEMBRANOMICS
- Serial number 76488863
- Registration number 2890826
- Filing date Feb 6, 2003
- Ganymed Pharmaceuticals AG
- 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
Information Trademark
76436732 - GANYMED
- Serial number 76436732
- Registration number 2796955
- Filing date Aug 2, 2002
- Ganymed Pharmaceuticals AG
- 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
Information Trademark
76307698 - MICROGATE
- Serial number 76307698
- Registration number 2708625
- Filing date Aug 31, 2001
- GANYMED PHARMACEUTICALS AG
- 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry

GANYMED PHARMACEUTICALS AG

Organization

Patents Grantslast 30 patents

Antibodies specific for claudin 6 (CLDN6)

Antibodies for treatment of cancer expressing claudin 6

Methods and compositions for diagnosis and treatment of cancer

Claudin-6-specific immunoreceptors and t cell epitopes

Antibodies for treatment of cancer expressing claudin 6

Cancer therapy using CLDN6 target-directed antibodies in vivo

Antibodies specific for claudin 6 (CLDN6)

Agents for treatment of claudin expressing cancer diseases

Genetic products differentially expressed in tumors and the use the...

Claudin-6-specific immunoreceptors and T cell epitopes

Antibodies for treatment of cancer expressing claudin 6

Monoclonal antibodies against claudin-18 for treatment of cancer

Therapy involving antibodies against Claudin 18.2 for treatment of...

Monoclonal antibodies for treatment of cancer

Agents for treatment of claudin expressing cancer diseases

Antibodies against claudin 18.2 useful in cancer diagnosis

Identification of surface-associated antigens for tumor diagnosis a...

Combination therapy involving antibodies against Claudin 18.2 for t...

Monoclonal antibodies against claudin-18 for treatment of cancer

Antibodies specific for claudin 6 (CLDN6)

Identification of tumor-associated antigens for diagnosis and therapy

Cancer therapy using CLDN6 target-directed antibodies in vivo

Methods and compositions for diagnosis and treatment of cancer

Antibody to genetic products differentially expressed in tumors and...

Combination therapy involving antibodies against claudin 18.2 for t...

Monoclonal antibodies against claudin-18 for treatment of cancer

Identification of tumour-associated cell surface antigens for diagn...

Cancer therapy using CLDN6 target-directed antibodies in vivo

Methods and compositions for diagnosis and treatment of cancer

Antibodies against Claudin 18.2 useful in cancer diagnosis

Patents Applicationslast 30 patents

ANTIBODIES FOR TREATMENT OF CANCER EXPRESSING CLAUDIN 6

ANTIBODIES SPECIFIC FOR CLAUDIN 6 (CLDN6)

CANCER THERAPY USING CLDN6 TARGET-DIRECTED ANTIBODIES IN VIVO

DRUG CONJUGATES COMPRISING ANTIBODIES AGAINST CLAUDIN 18.2

METHODS AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF CANCER

CLAUDIN-6-SPECIFIC IMMUNORECEPTORS AND T CELL EPITOPES

ANTIBODIES FOR TREATMENT OF CANCER EXPRESSING CLAUDIN 6

CANCER THERAPY USING CLDN6 TARGET-DIRECTED ANTIBODIES IN VIVO

Agents for Treatment of Claudin Expressing Cancer Diseases

DIAGNOSIS AND THERAPY OF CANCER INVOLVING CANCER STEM CELLS

ANTIBODIES SPECIFIC FOR CLAUDIN 6 (CLDN6)

CLAUDIN-6-SPECIFIC IMMUNORECEPTORS AND T CELL EPITOPES

METHODS AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF CANCER

THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR TREATMENT OF...

Agents for Treatment of Claudin Expressing Cancer Diseases

ANTIBODIES FOR TREATMENT OF CANCER EXPRESSING CLAUDIN 6

COMBINATION THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR T...

ANTIBODIES AGAINST CLAUDIN 18.2 USEFUL IN CANCER DIAGNOSIS

COMBINATION THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR T...

ANTIBODIES SPECIFIC FOR CLAUDIN 6 (CLDN6)

CANCER THERAPY USING CLDN6 TARGET-DIRECTED ANTIBODIES IN VIVO

MONOCLONAL ANTIBODIES AGAINST CLAUDIN-18 FOR TREATMENT OF CANCER

DRUG CONJUGATES COMPRISING ANTIBODIES AGAINST CLAUDIN 18.2

METHODS AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF CANCER

METHODS AND COMPOSITIONS FOR PREDICTION OF THERAPEUTIC EFFICACY OF...

COMBINATION THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR T...

Genetic Products Differentially Expressed In Tumors And The Use The...

GENETIC PRODUCTS DIFFERENTIALLY EXPRESSED IN TUMORS AND THE USE THE...

GENETIC PRODUCTS DIFFERENTIALLY EXPRESSED IN TUMORS AND USE THEREOF

Monoclonal Antibodies for Treatment of Cancer

Trademarklast 30 trademarks

85850550 - CLAUDETECT

85850578 - GANYMED

76686277 - GANYMED

76488861 - MEMBRANOME

76488863 - MEMBRANOMICS

76436732 - GANYMED

76307698 - MICROGATE